Figure 7 | Scientific Reports

Figure 7

From: Identification of molecular classification and gene signature for predicting prognosis and immunotherapy response in HNSCC using cell differentiation trajectories

Figure 7

Validation of the risk assessment model. (A) Survival rates in high-risk HNSCC patients (TCGA and GEO) were considerably lower than in low-risk individuals. (B) In the TCGA collection, the ROC curves for predicting 1-year, 3-year, and 5-year AUC values were 0.639, 0.654, and 0.673, respectively, and in the GSE117973 set, they were 0.834, 0.736, and 0.752, respectively. (C) The expression levels of 10 DRGs.

Back to article page